Medical Device Cybersecurity: Buyer Questions
Medical device cybersecurity should be evaluated across the full device lifecycle. Buyers need clear answers on secure design, identity, updates, vulnerability handling, logging, incident response, and what happens when the device reaches end of support.
Why is medical device cybersecurity a buying issue?
A medical device is part of a care environment, not an isolated piece of hardware. It may connect to clinical systems, receive updates, handle sensitive information, or support a workflow where downtime matters. Cybersecurity therefore affects procurement, deployment, operations, and retirement.
The FDA medical device cybersecurity guidance is a useful reference for understanding secure product development and post-market responsibilities. A buyer should use it as a starting point, then align the review with local regulation, hospital policy, and the device’s intended use.
The first question is not whether a product is secure in the abstract. It is whether the supplier and the buyer can identify, reduce, detect, and respond to the risks created by this device in this environment.
Shortcut: ask what the supplier will do on an ordinary day, during an incident, and after support ends.
Which lifecycle questions belong in the RFP?
Cybersecurity requirements should appear before the purchase decision, not as a technical appendix after the preferred supplier is chosen. The RFP should make the supplier describe the device, its dependencies, its update path, and the responsibilities that remain with the buyer.
Avoid asking only for a certificate or a yes-or-no control list. Ask for evidence that can be checked during deployment and operation. If a control cannot be observed, it is difficult to manage.
- Architecture: which components, services, interfaces, and external dependencies are required?
- Identity and access: how are users, service accounts, administrators, and remote support sessions controlled?
- Updates: how are patches tested, approved, delivered, rolled back, and communicated?
- Vulnerability handling: how can a buyer report a weakness and receive a timely, useful response?
- Resilience: what is the safe operating mode if the network, supplier service, or device software is unavailable?
How should buyers review the software bill of materials?
A software bill of materials can help a buyer understand which components are present and where dependency risk may arise. It is not a complete security assessment. The buyer still needs to know how components are monitored, patched, and tested in the delivered product.
Ask which format is supplied, how often it is updated, and how changes are communicated. Ask what the supplier does when a component reaches end of support or a vulnerability is disclosed. The answer should describe a process, not a promise that problems will never occur.
Keep the bill of materials connected to asset records and support contacts. A document stored in procurement and forgotten after installation will not help the operations team during an incident.
| Question | What a useful answer includes | Evidence to retain |
|---|---|---|
| What is included? | Components, versions, and product scope. | Current SBOM and product version. |
| How are changes tracked? | Update trigger, review, and notification route. | Change records and notices. |
| How are vulnerabilities handled? | Triage, remediation, mitigation, and communication. | Advisory process and response contacts. |
| What is the buyer’s role? | Local controls, segmentation, access, and monitoring. | Deployment and operating procedures. |
What should deployment security cover?
Deployment is where a product’s documented design meets a real network, a real identity system, and real users. The buyer should approve the connection design before the device is placed into service. Segment devices where appropriate, limit administration paths, remove default access, and record every external dependency.
Remote support deserves special attention. Temporary access should have a business reason, an expiry, a named approver, and a log. If a supplier cannot explain how support sessions are controlled and reviewed, the buyer should treat that as a material gap.
Test the device in a representative environment. Confirm what happens when a service is unreachable, credentials expire, certificates change, or an update is rejected. These are operational questions with security consequences.
- Inventory: record device identity, software version, owner, location, network role, and support status.
- Segmentation: restrict connections to the systems the device actually needs.
- Administration: use named accounts, least privilege, strong authentication, and reviewable logs.
- Monitoring: forward useful events to the team that can act on them.
- Recovery: document safe fallback, restoration, and replacement steps.
Incident response and vulnerability disclosure
A security event involving a device may affect care delivery, data, safety, and trust at the same time. The supplier and buyer should agree in advance on who declares an incident, who communicates with users, how evidence is preserved, and how clinical or operational continuity is protected.
Use the CISA cyber threat and advisory resources to keep the organisation’s broader response practice current, but do not assume a general incident plan covers device-specific decisions. The device owner needs a playbook with supplier contacts, technical steps, clinical or operational escalation, and regulatory review triggers.
Ask how the supplier handles coordinated vulnerability disclosure. A mature answer explains intake, validation, customer notice, mitigation, patching, and follow-up. It does not require the buyer to find a public notice after the risk is already active.
- Identify the device, affected workflow, and safe operating state.
- Limit access and preserve logs without disrupting essential care.
- Notify the supplier and internal response owners through the agreed route.
- Decide on mitigation, patch, replacement, or temporary isolation.
- Record the lesson and update the device risk record before returning to normal.
Medical device cybersecurity operating models compared
The correct operating model depends on how much technical and clinical responsibility the buyer can carry. A supplier-managed service may reduce local work but increase dependency on contract terms and service visibility.
The comparison should cover both normal operations and failure. A low-price model that leaves the buyer with no update route, no useful logs, or no support after a vulnerability is disclosed is not low risk.
| Model | Best fit | Buyer must control | Main trade-off |
|---|---|---|---|
| Supplier-managed service | Connected devices with clear managed support | Access, data, escalation, and service continuity | Less local work, more supplier dependency |
| Locally operated device | Sites with strong technical teams | Network, identity, updates, and monitoring | More control, more operating responsibility |
| Hybrid responsibility | Mixed clinical and technical ownership | The handoffs and evidence at each boundary | Flexible, but gaps can hide between teams |
| Isolated deployment | High sensitivity or limited connectivity | Physical access, updates, and recovery | Reduced exposure, harder maintenance |
What does not matter as much as buyers think?
A product brochure can list encryption, secure development, and monitoring without showing how those controls work in a hospital or clinic. A one-time penetration test is useful evidence, but it does not replace vulnerability handling, update discipline, or operational monitoring.
The stronger signal is traceability. Can the buyer connect a device to an owner, a version, a support route, a risk record, and a recovery procedure? If not, the organisation is buying an asset it may struggle to govern.
One-page buyer worksheet
Use this worksheet in the RFP and deployment review. Record the device identity, software version, connections, administrators, remote support route, update method, vulnerability contact, logging, recovery state, and end-of-support plan.
Keep the worksheet with the research brief, procurement record, or operating review. It turns a broad market question into a set of checks that can be answered, assigned, and revisited when new evidence arrives.
- Device and component inventory with named owner
- Identity, privilege, and remote support controls
- Update, rollback, and vulnerability response process
- Safe operating mode during service or network loss
- Lifecycle, replacement, and end-of-support decision
FAQ
What is the first medical device cybersecurity question to ask?
Ask what the device connects to, who can administer it, how it is updated, and what safe operation looks like when those connections are unavailable.
Is an SBOM enough to approve a device?
No. An SBOM helps identify components. Approval also needs evidence about access, updates, vulnerabilities, logging, incident response, and lifecycle support.
Who owns device cybersecurity after procurement?
Ownership should be shared explicitly between the device owner, technical operations, security, clinical or operational leadership, and the supplier. The contract should record the boundaries.
How should remote support be controlled?
Use named access, an approved purpose, strong authentication, limited duration, least privilege, and logs that the buyer can review.
What happens when a device reaches end of support?
The buyer should have a documented plan for isolation, replacement, migration, or risk acceptance. End of support should never be discovered during an incident.
Bottom line
Need a broader view of healthcare cybersecurity and device markets? Read the healthcare cybersecurity buyer framework or speak with an analyst.